MedhaviGuptaMD

Physician

Dr. Gupta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1 Blackstone Street
3RD floor
Providence, RI 02903
Phone+1 401-453-7520

Fax+1 401-453-7529

Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2015 - 2018
Icahn School of Medicine at Mount Sinai (Bronx)Residency, Internal Medicine, 2015 - 2018
B. J. Medical College AhmedabadClass of 2013

PubMed

1 citations
Evaluation of the serotonin pathway as a biomarker in cholangiocarcinoma.
Christos Fountzilas, Sylvia Alarcon Velasco, Wiam Bshara, Charles M LeVea, Medhavi Gupta
Journal of Gastrointestinal Oncology. 2023-10-31
11 citations
Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer.
Yara Abdou, Medhavi Gupta, Mariko Asaoka, Kristopher Attwood, Opyrchal Mateusz
Scientific Reports. 2022-08-04
9 citations
Health-Related Quality of Life (HRQoL) in Neuroendocrine Tumors: A Systematic Review.
Rohit Gosain, Medhavi Gupta, Arya Mariam Roy, Jonathan Strosberg, Kathryn M Glaser
Cancers. 2022-03-10

Lectures

A phase II study of trifluridine/tipiracil, irinotecan, and bevacizumab in pretreated metastatic colorectal cancer (TABAsCO).
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
Phase II study of nanoliposomal irinotecan (nal-IRI) with 5-fluorouracil (5-FU)/folinic acid (FA) in refractory advanced high-grade neuroendocrine cancer (HG-NEC) of g...
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020